EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Engineered anti-HER2 drug delivery nanosystems for the treatment of breast cancer

Silvia Vanni, Tania Mariastella Caputo, Angela Maria Cusano, Alessandro De Vita, Andrea Cusano, Claudia Cocchi, Chiara Mulè, Sofia Principe, Chiara Liverani, Giorgia Celetti, Alberto Micco, Chiara Spadazzi und 4 weitere

Nanoscale · 2025 · 17 (15) · 9436-9457

DOI: 10.1039/d4nr03907f ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nanoscale, 2025. Verfasst von Silvia Vanni und 15 weiteren Autor:innen. Beteiligte Einrichtung: Preclinic and Osteoncology Unit, Biosciences Laboratory, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori", Meldola, Italy. ale…. Hauptthemen laut MEDLINE: Breast Neoplasms, Erb-b2 Receptor Tyrosine Kinases, Trastuzumab, Nanoparticles. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 86 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Schematic representation of clinical and pre-clinical workflow settings for light controlled release of PLGA NPs for breast cancer treatment. Created in BioRender.com. Vanni, S. (2025) https://BioRender.com/r11b297.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsErb-b2 Receptor Tyrosine KinasesTrastuzumabNanoparticlesDrug CarriersDrug Delivery SystemsAntineoplastic AgentsHumansFemalePolylactic Acid-Polyglycolic Acid CopolymerCell Line, TumorApoptosisCell SurvivalPolyglycolic AcidLactic Acid

Substanzen

Polylactic Acid-Polyglycolic Acid CopolymerErb-b2 Receptor Tyrosine KinasesTrastuzumabPolyglycolic AcidDrug CarriersLactic AcidAntineoplastic AgentsERBB2 protein, human

Autor:innen und Institutionen

  • Preclinic and Osteoncology Unit, Biosciences Laboratory, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori", Meldola, Italy. alessandro.devita@irst.emr.it.
  • Optoelectronics Group, Department of Engineering, University of Sannio, Benevento, Italy. a.cusano@unisannio.it.
  • CeRICTscrl Regional Center Information Communication Technology, Benevento, Italy.
  • Osteoncology, Bone and Soft Tissue Sarcomas and Innovative Therapies Unit, IRCCS Istituto Ortopedico Rizzoli, Bologna, Italy.

Zitieren

APA

Vanni, S., Caputo, T. M., Cusano, A. M., De Vita, A., Cusano, A., Cocchi, C., Mulè, C., Principe, S., Liverani, C., Celetti, G., Micco, A., Spadazzi, C., Miserocchi, G., Ibrahim, T., Mercatali, L., & Aliberti, A. (2025). Engineered anti-HER2 drug delivery nanosystems for the treatment of breast cancer. Nanoscale, 17(15), 9436-9457. https://doi.org/10.1039/d4nr03907f

Vancouver

Vanni S, Caputo TM, Cusano AM, De Vita A, Cusano A, Cocchi C, et al. Engineered anti-HER2 drug delivery nanosystems for the treatment of breast cancer. Nanoscale. 2025;17(15):9436-9457. doi:10.1039/d4nr03907f

BibTeX
@article{Vanni2025,
  author = {Vanni, Silvia and Caputo, Tania Mariastella and Cusano, Angela Maria and De Vita, Alessandro and Cusano, Andrea and Cocchi, Claudia and Mulè, Chiara and Principe, Sofia and Liverani, Chiara and Celetti, Giorgia and Micco, Alberto and Spadazzi, Chiara and Miserocchi, Giacomo and Ibrahim, Toni and Mercatali, Laura and Aliberti, Anna},
  title = {Engineered anti-HER2 drug delivery nanosystems for the treatment of breast cancer},
  journal = {Nanoscale},
  year = {2025},
  volume = {17},
  number = {15},
  pages = {9436--9457},
  doi = {10.1039/d4nr03907f}
}
Kostenlos starten →